Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial

OBJECTIVE: Many patients receiving dual antiplatelet therapy still had recurrent strokes. We aimed to identify factors associated with recurrent stroke at 90 days in patients receiving dual antiplatelet therapy in Clopidogrel in High-risk patients with Acute Non-disabling Cerebrovascular Events tria...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stroke Vasc Neurol
Main Authors: Wangqin, Runqi, Wang, Xianwei, Wang, Yilong, Xian, Ying, Zhao, Xingquan, Liu, Liping, Li, Hao, Meng, Xia, Wang, Yongjun
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5829906/
https://ncbi.nlm.nih.gov/pubmed/29507777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/svn-2017-000088
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados